These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36089583)

  • 1. Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro.
    Guo T; Sun X; Yang J; Yang L; Li M; Wang Y; Jiao H; Li G
    BMC Microbiol; 2022 Sep; 22(1):215. PubMed ID: 36089583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G; Mao Y; Sun Y
    Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
    Goff DA; Kaye KS
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
    Castanheira M; Mendes RE; Jones RN
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Minocycline: A Review in Acinetobacter Infections.
    Greig SL; Scott LJ
    Drugs; 2016 Oct; 76(15):1467-1476. PubMed ID: 27573640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.
    Liang W; Liu XF; Huang J; Zhu DM; Li J; Zhang J
    BMC Infect Dis; 2011 Apr; 11():109. PubMed ID: 21521536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence and spread of plasmid-borne tet(B)::ISCR2 in minocycline-resistant Acinetobacter baumannii isolates.
    Vilacoba E; Almuzara M; Gulone L; Traglia GM; Figueroa SA; Sly G; Fernández A; Centrón D; Ramírez MS
    Antimicrob Agents Chemother; 2013 Jan; 57(1):651-4. PubMed ID: 23147737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
    Ku NS; Lee SH; Lim YS; Choi H; Ahn JY; Jeong SJ; Shin SJ; Choi JY; Choi YH; Yeom JS; Yong D; Song YG; Kim JM
    Sci Rep; 2019 Nov; 9(1):17127. PubMed ID: 31748527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin B Combined with Minocycline: A Potentially Effective Combination against bla
    Qu X; Bian X; Chen Y; Hu J; Huang X; Wang Y; Fan Y; Wu H; Li X; Li Y; Guo B; Liu X; Zhang J
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY; Ng LS; Tan E; Huang G
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
    Yang YS; Lee Y; Tseng KC; Huang WC; Chuang MF; Kuo SC; Lauderdale TL; Chen TL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4047-54. PubMed ID: 27114274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii.
    Beganovic M; Luther MK; Daffinee KE; LaPlante KL
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):223-226. PubMed ID: 30827805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
    Beganovic M; Daffinee KE; Luther MK; LaPlante KL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
    [No Abstract]   [Full Text] [Related]  

  • 17. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson KJ; Thamlikitkul V; Dudley MN; Redell MA
    Int J Antimicrob Agents; 2018 Sep; 52(3):404-406. PubMed ID: 29665446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.